Patents by Inventor Shing-Hwa Liu

Shing-Hwa Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9017657
    Abstract: The invention relates to a cell culture method, particularly to a co-culture method for human mesenchymal stem cells and target animal cells, in order to solve the problem that animal cells are not easy to survive alone upon culturing. The invention also provides a method for using a stem cell conditioned medium to culture animal cells. The invention also provides a method to induce the transformation of human fetal islet-like cell clusters from human stem cells and its application thereof.
    Type: Grant
    Filed: January 15, 2009
    Date of Patent: April 28, 2015
    Assignee: National Taiwan University
    Inventors: Shing-Hwa Liu, Kuo-Ching Chao, Kuo-Fang Chao
  • Patent number: 8633252
    Abstract: This invention relates to the use of pterosin compounds of formula I for treating diabetes including type I and type II. Also disclosed is the use of the pterosin compounds for treating obesity.
    Type: Grant
    Filed: January 26, 2010
    Date of Patent: January 21, 2014
    Assignees: Taipei Medical University, National Taiwan University, National Tsing Hua University, DCB-USA LLC
    Inventors: Feng-Lin Hsu, Shing-Hwa Liu, Biing-Jiun Uang
  • Publication number: 20100190732
    Abstract: This invention relates to the use of pterosin compounds of formula I for treating diabetes including type I and type II. Also disclosed is the use of the pterosin compounds for treating obesity.
    Type: Application
    Filed: January 26, 2010
    Publication date: July 29, 2010
    Applicants: Taipei Medical University, National Taiwan University, National Tsing Hua University, DCB-USA, LLC
    Inventors: Feng-Lin Hsu, Shing-Hwa Liu, Biing-Jiun Uang
  • Publication number: 20100015103
    Abstract: The invention relates to a cell culture method, particularly to a co-culture method for human mesenchymal stem cells and target animal cells, in order to solve the problem that animal cells are not easy to survive alone upon culturing. The invention also provides a method for using a stem cell conditioned medium to culture animal cells. The invention also provides a method to induce the transformation of human fetal islet-like cell clusters from human stem cells and its application thereof.
    Type: Application
    Filed: January 15, 2009
    Publication date: January 21, 2010
    Applicant: National Taiwan University
    Inventors: Shing-Hwa Liu, Kuo-Ching Chao, Kuo-Fang Chao